FdaApplication
NDA 216157
Identifiers
- fda_app_no: NDA216157
Properties
| Property | Value |
|---|---|
| applicant_name | GLOBAL BLOOD THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2021-12-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXBRYTA | VOXELOTOR | 500MG | TABLET;ORAL |
| OXBRYTA | VOXELOTOR | 300MG | TABLET, FOR SUSPENSION;ORAL |
2 products